Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1287616

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1287616

Anti-Venom Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

PUBLISHED:
PAGES: 145 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2499
PDF & Excel (5 User License)
USD 3499
PDF & Excel (Corporate License)
USD 4499

Add to Cart

Market Overview:

The global anti-venom market size reached US$ 1,096.1 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,644.9 Million by 2028, exhibiting a growth rate (CAGR) of 6.7% during 2023-2028.

Anti-venoms are purified antibodies used to stop snake venom from binding to tissues and causing severe allergic reactions, blood-clotting, muscle injury, or nervous system problems. They can prevent or reverse the snakebite envenoming effects, which help minimize mortality and morbidity. They are obtained from different animal species, such as snakes, funnel web spiders, stonefish, redback spiders, and box jellyfish, using different technologies. Presently, the type of anti-venom generally used depends on the history and examination of the patient and geographic, clinical, and pathologic factors.

Anti-Venom Market Trends:

The risk of snakebite envenoming is a public health hazard that people, especially in the rural areas, experience on a regular basis. It causes occupational injury among several agricultural workers and hunters, which represents one of the key factors driving the need for safe, effective, and affordable anti-venoms. In addition, open-plan housing and the practice of sleeping on the floor, common in tropical regions, can expose people to bites from nocturnal and highly venomous snakes and cause serious health problems. These health problems usually include kidney failure, severe paralysis that prevents breathing, bleeding disorders that can lead to fatal hemorrhage, and severe local tissue destruction that can cause permanent disability and result in limb amputation. This, in turn, is catalyzing the demand for anti-venoms across the globe. Apart from this, there is an introduction of snake venom detection kits with a rapid enzyme immunoassay for in vitro detection and immunological identification of snake venom in samples from bite sites, urine, plasma, blood, or other tissues and body fluids. This is anticipated to offer lucrative growth opportunities to industry players and drive the overall market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-venom market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on species, anti-venom type, mode of action and end user.

Breakup by Species:

  • Snake
  • Scorpion
  • Spider
  • Others

Breakup by Anti-venom Type:

  • Polyvalent Anti-venom
  • Monovalent Anti-venom

Breakup by Mode of Action:

  • Cytotoxic
  • Neurotoxic
  • Haemotoxic
  • Cardiotoxic
  • Myotoxic
  • Others

Breakup by End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH, Boston Scientific Corporation, CSL Limited, Haffkine Bio-Pharmaceutical Corporation Limited, Incepta Pharmaceuticals Limited, Merck & Co. Inc., Merck KGaA, MicroPharm Limited, Pfizer Inc. and Rare Disease Therapeutics Inc.

Key Questions Answered in This Report:

  • What was the size of the global anti-venom market in 2022?
  • What is the expected growth rate of the global anti-venom market during 2023-2028?
  • What has been the impact of COVID-19 on the global anti-venom market?
  • What are the key factors driving the global anti-venom market?
  • What is the breakup of the global anti-venom market based on the species?
  • What is the breakup of the global anti-venom market based on the anti-venom type?
  • What is the breakup of the global anti-venom market based on the mode of action?
  • What is the breakup of the global anti-venom market based on the end user?
  • What are the key regions in the global anti-venom market?
  • Who are the key players/companies in the global anti-venom market?
Product Code: SR1623A374_Report

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Anti-venom Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Species

  • 6.1  Snake
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Scorpion
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Spider
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7   Market Breakup by Anti-venom Type

  • 7.1  Polyvalent Anti-venom
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Monovalent Anti-venom
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8   Market Breakup by Mode of Action

  • 8.1  Cytotoxic
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Neurotoxic
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Haemotoxic
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4  Cardiotoxic
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5  Myotoxic
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6  Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9   Market Breakup by End User

  • 9.1  Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3  Ambulatory Surgical Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  Bharat Serums and Vaccines Limited (BSV) 
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2  Boehringer Ingelheim International GmbH
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3  Boston Scientific Corporation
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4  CSL Limited
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5  Haffkine Bio-Pharmaceutical Corporation Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6  Incepta Pharmaceuticals Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7  Merck & Co. Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8  Merck KGaA
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9  MicroPharm Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10  Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11  Rare Disease Therapeutics Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
Product Code: SR1623A374_Report

List of Figures

  • Figure 1: Global: Anti-venom Market: Major Drivers and Challenges
  • Figure 2: Global: Anti-venom Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Anti-venom Market: Breakup by Species (in %), 2022
  • Figure 5: Global: Anti-venom Market: Breakup by Anti-venom Type (in %), 2022
  • Figure 6: Global: Anti-venom Market: Breakup by Mode of Action (in %), 2022
  • Figure 7: Global: Anti-venom Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Anti-venom Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Anti-venom (Snake) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Anti-venom (Snake) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Anti-venom (Scorpion) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Anti-venom (Scorpion) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Anti-venom (Spider) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Anti-venom (Spider) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Anti-venom (Other Species) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Anti-venom (Other Species) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Anti-venom (Polyvalent Anti-venom) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Anti-venom (Polyvalent Anti-venom) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Anti-venom (Monovalent Anti-venom) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Anti-venom (Monovalent Anti-venom) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Anti-venom (Cytotoxic) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Anti-venom (Cytotoxic) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Anti-venom (Neurotoxic) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Anti-venom (Neurotoxic) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Anti-venom (Haemotoxic) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Anti-venom (Haemotoxic) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Anti-venom (Cardiotoxic) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Anti-venom (Cardiotoxic) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Anti-venom (Myotoxic) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Anti-venom (Myotoxic) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Anti-venom (Other Mode of Actions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Anti-venom (Other Mode of Actions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Anti-venom (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Anti-venom (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Anti-venom (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Anti-venom (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Anti-venom (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Anti-venom (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: North America: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: North America: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: United States: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: United States: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Canada: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Canada: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia-Pacific: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Asia-Pacific: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: China: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: China: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Japan: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Japan: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: India: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: India: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: South Korea: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: South Korea: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Australia: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Australia: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Indonesia: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Indonesia: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Europe: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Europe: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Germany: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Germany: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: France: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: France: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: United Kingdom: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: United Kingdom: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Italy: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Italy: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Spain: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Spain: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Russia: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Russia: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Latin America: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Latin America: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Brazil: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Brazil: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Mexico: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Mexico: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Others: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Others: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Middle East and Africa: Anti-venom Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Middle East and Africa: Anti-venom Market: Breakup by Country (in %), 2022
  • Figure 87: Middle East and Africa: Anti-venom Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Anti-venom Industry: SWOT Analysis
  • Figure 89: Global: Anti-venom Industry: Value Chain Analysis
  • Figure 90: Global: Anti-venom Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anti-venom Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Anti-venom Market Forecast: Breakup by Species (in Million US$), 2023-2028
  • Table 3: Global: Anti-venom Market Forecast: Breakup by Anti-venom Type (in Million US$), 2023-2028
  • Table 4: Global: Anti-venom Market Forecast: Breakup by Mode of Action (in Million US$), 2023-2028
  • Table 5: Global: Anti-venom Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Anti-venom Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Anti-venom Market: Competitive Structure
  • Table 8: Global: Anti-venom Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!